Under unprecedented time and cost pressures, many life sciences teams have reached for off-the-shelf AI tools to stay afloat. Yet they have discovered that generic AI tools introduce new risks, such as hallucination. Tools that cannot withstand scientific or regulatory scrutiny are a liability in MLR review, portfolio committees, and investment decisions where every claim must be traceable to a source.
More than isolated tools, teams need a purpose-built intelligence layer designed for the rigor that the industry demands. Across life sciences functions, platforms like AlphaSense are streamlining the entire decision cycle. This report covers the top AI use cases that have transformed how the industry’s leading teams reach defensible answers.
